ANALYSIS OF IMMUNOHISTOCHEMICAL REACTIONS OF VARIOUS PD-L1 CLONES IN PROSTATE ADENOCARCINOMA
Journal: Cardiometry
Year: 2022

Prostate cancer (PC) is the most commonly diagnosed malignancy in men. The standard treatment for localized PC is radical prostatectomy, but recurrence is a significant problem in this case. The main prognostic markers of the disease recurrence are the Gleason score and the preoperative level of the prostate-specific antigen (PSA), which determines the need to identify some key molecules of the PC progression. This can be useful in identifying new prognostic markers or targeted treatments for th